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388 May peripherally inserted central catheters (PICC) be
an alternative for implantable catheter ports (ICP) for
intravenous (IV) antibiotic therapy?
C. Dupont1, D. Hubert1, S. Marque2, C. Cracowski3, L. Agrario1, T. Wagner1.
1CF center, Hoˆpital Cochin, Paris, France; 2Medical Intensive Care Unit, Hoˆpital
Cochin, Paris, France; 3CF Center, Hoˆpital de la Tronche, Grenoble, France
Background: PICC may be an alternative to ICP for IV antibiotic therapy for Cystic
Fibrosis (CF) or bronchiectasies patients with unfrequent IV antibiotic therapies,
frequent inﬁltrations with peripheral-short catheters and refusal of ICP.
Methods: We started using PICCs in 2 adult CF centers (Hoˆpital Cochin, Paris and
Hoˆpital de la Tronche, Grenoble) in 2006 and prospectively gathered data of the
insertion procedure, the outcome and complications during therapy.
Results: PICC insertions were performed in the intensive care unit by intensive care
physicians (Cochin) or by a physician of the nutrition department (La Tronche). All
12 patients were female (age: 20 to 74 years), 9 were treated for CF, 3 for bronchiec-
tasies of unknown origin. They received between 0 and 3 IV antibiotic therapies per
year. Eight (61.5%) insertions attempts were successful, 5 failed because of difﬁcult
guide wire advancement. Seven antibiotic therapies were performed at home and 1
in the hospital for a duration between 7 to 22 days. Systematic echodoppler revealed
no venous thrombosis. Systematic bacterial cultures of PICC tips at removal showed
no infection. All 8 patients were satisﬁed and willing for a 2nd PICC.
Conclusion: PICC may be an alternative for ICPs in a selected population of adult
patients receiving IV antibiotic therapy. No complications were reported and patients
were satisﬁed. Failures origin may be anatomic venous difﬁculties or insufﬁciently
trained insertion providers because of a new use of PICCs in CF. Echodoppler-
oriented insertion may increase the rate of successful attempts.
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Patients with cystic ﬁbrosis (CF) experience repeated infective respiratory exac-
erbations leading to a continous decline in lung function. The exacerbations are
treated with intravenous antibiotic courses in hospital or at home.
Our aim was to compare the clinical outcome for patients undergoing intravenous
antibiotic treatment either at home or in hospital.
A retrospective 10-year study was performed in 4 regional CF centres. The outcome
measures were percentage changes in forced expiratory volume in 1 second (FEV1),
forced vital capacity (FVC) and z-score. FEV1, FVC and z-score changes were
calculated for the entire study period and for each course of intravenous treatment.
A total of 153 patients were analysed (51 inpatients matched to 103 patients treated
at home). The two groups had no signiﬁcant differences in any outcome variable
at baseline. The mean variation per year in FEV1 was greater in the hospital group
versus the home group (−0.4% vs −1.8%; p = 0.03). The mean variation per year
in z-score was greater in the hospital group versus the home group (p< 0.01). A
total of 1,160 intravenous antibiotic courses were analysed. For each course, the
mean improvement in FEV1 and FVC was signiﬁcantly higher when performed
in hospital than when performed at home (p< 0.05). FEV1 and FVC values were
10.2% and 9.5% respectively in the hospital group and 7.3% and 6.8% in the home
group.
Clinical outcome, as deﬁned by spirometric parameters and body weight, was better
after a course of treatment in hospital than after a home treatment. This beneﬁt was
maintained throughout of the study period.
Supported by: Vaincre la Mucoviscidose; Programme Hospitalier de Recherche
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390 Socio-economic deprivation in the North West of England predicts
work status in adult cystic ﬁbrosis patients
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With improving life expectancy, the availability of work becomes increasingly important
in CF, but little is known about which clinical, demographic and social factors may
inﬂuence work status in these patients. To look at this further, we compared employment
status with a group of clinical parameters and also residential deprivation status (based
on the UK Multiple Deprivation [IMD] 2004, low score = worse) in a group of 118
adult CF patients, 73 of whom (62%) were in employment.
There was no difference between employed and unemployed patients in terms of their
gender, age, lung function, number of visits to out-patient clinics, and number of
courses and IV antibiotic days (see table).
However, unemployed patients were signiﬁcantly more deprived (mean IMD score 7,300
vs 10,100; p = 0.012). Furthermore, when comparing patients from the most deprived
areas (28 patients, IMD 1–900) with those from the least deprived (35 patients, IMD
20,000–32,482), 50% and 17% respectively were unemployed (c2 = 7.75; p< 0.01).
Thus, in our cohort of CF patients, socio-economic deprivation was the only predictor
of their work status, whilst other clinical and demographic factors seemed to play little
or no role in differentiating between employed and unemployed patients.
Nevertheless, the overall number of our CF patients engaged in work was high, which
may reﬂect a constantly improving health status and quality of life in adult CF.
Males n
(%)
Mean
age
Mean
FEV1%
2 year
DFEV1
Diabetes
n (%)
Clinic
visits
hospital
antibiotics
home
antibiotics
Mean
courses
Mean
days
Mean
courses
Mean
days
Unemployed 28 (62%) 26.6 63.5 −0.24 18 (40%) 19 4.2 63.3 1.9 27.5
Employed 33 (45%) 27.9 71.8 −0.23 19 (26%) 18 5 72.7 2 29.3
P value ns ns ns ns ns ns ns ns ns ns
391 Residential deprivation has no adverse effects on clinical
parameters in adult CF patients
A. Youzguin, H. Burhan, M.J. Walshaw, M.J. Ledson. Regional Adult CF Unit, The
Cardiothoracic Centre, Liverpool, United Kingdom
It has been shown that, independent of socioeconomic status and smoking habits,
individuals living in more deprived areas in the UK have worse lung function (ERJ
2004; 24: 157−61) and increased hospital admissions for respiratory infection (Respir
Med 2003; 97: 1219−24). However, it is not known whether residential deprivation
has an impact on the health of adult CF patients. To look at this further, we compared
clinical parameters in 162 adult CF patients attending our centre (serving a large region
in North West England) with the UK Index of Multiple Deprivation (IMD) 2004 (1 =
most deprived, 32,482 = most afﬂuent).
We found no correlation between IMD and patients gender, age, BMI, FEV1%,
change in FEV1 over 2 years, presence of diabetes, courses/days of hospital and home
antibiotics, and average length of stay in hospital. Furthermore, those living in the most
deprived areas (IMD 1−6,900; 76 patients, 55%) had similar clinical parameters to the
remainder (see table).
Thus, unlike the general population, in adult CF patients residential deprivation is not
associated with poorer health, including lung function. One explanation of this could
be that the special healthcare provision for all CF patients in the UK overrides the
effects of deprivation, and this could be used as a model for improving the health of
other patients.
Deprivation
score
Males
(%)
Mean
age
Mean
BMI
Mean
FEV1%
Mean
DFEV1 (L)
Diabetes
(%)
Home IVs
(3 years)
Hospital IVs
(3 years)
Staya
Mean
courses
Mean
days
Mean
courses
Mean
days
IMD
1−6,900
42
(55)
24.3 21.6 75.6 −0.25 21 (28) 2.2 31.6 3.6 54.4 10.1
IMD
7,000
45
(52)
25.8 22 68.3 −0.18 25 (29) 2.1 29.6 5.2 74.8 11.1
p value ns ns ns ns ns ns ns ns ns ns ns
aMean length of stay (days).
